A mismatch between two common tests for kidney function may indicate a higher risk for kidney failure, heart disease, and ...

In the Chronic Kidney Disease Prognosis Consortium, 11% of outpatient participants and 35% of hospitalized patients had a cystatin ...

Doctors decided against performing an angiogram or angioplasty immediately, citing elevated creatinine levels, which posed a ...

Sparsentan therapy was associated with sustained decline in proteinuria and lower likelihood of progression to kidney failure ...

The results of two large-scale studies demonstrate that sodium-glucose co-transporter 2 (SGLT2) inhibitors significantly ...

In late-breaking presentations at the American Society of Nephrology Kidney Week meeting and simultaneously published in two ...

Chronic kidney disease develops silently. Kidneys filter waste, but when they weaken, toxins build up. This impacts the heart ...

Weight-loss medicines like Semaglutide (GLP – 1RA), originally developed to help people with type 2 diabetes manage their ...

Late-breaking presentation of Explore-CKD trial at ASN Kidney Week – – Pivotal Phase 3 Launch-HTN trial featured in the “Best of JAMA and NEJM” session - RADNOR, Pa., ...

A mismatch between two common tests for kidney function may indicate a higher risk for kidney failure, heart disease, and death, a new study ...

German pharma major Bayer announced new Phase III investigational data from the pivotal FINE-ONE trial showing that Kerendia ...